Bob Bradway

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Amgen Inc publishes a filing, an earnings call transcript or a press release.

About Bob Bradway

Bob Bradway is recorded as CEO at Amgen Inc (AMGN). Bob Bradway has spoken on 13 earnings calls across 1 company, most recently for Amgen Inc on April 8, 2026. Amgen Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Amgen Inc includes Robert Bradway (CEO), David W. Meline (CFO), Thomas Dittrich (CFO) and 7 others.

Bob Bradway on recent calls

“Our strong results were driven by the breadth and depth of our portfolio and once again demonstrate our ability to grow through patent expirations and increased competition.”

CEO, Amgen Inc Q2 FY2026 Earnings Call · April 8, 2026

“Today, we'll cover full-year results for 2025 and provide a preview of what to expect from us in 2026. Amgen delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business.”

CEO, Amgen Inc Q4 FY2025 Earnings Call · February 3, 2026

“We're off to a strong start in 2025 and this was an exciting quarter, one with strong volume growth across the enterprise, important new product launches, and positive Phase III data.”

CEO, Amgen Inc Q1 FY2025 Earnings Call · May 1, 2025

“Well, thank you, Justin, and let me thank all of you for joining the call today. We're especially grateful in light of all the volatility in the markets that you would carve out the time to be with us.”

CEO, Amgen Inc Q2 FY2024 Earnings Call · August 6, 2024

“It was an excellent quarter across the board for Amgen and one that demonstrates why we remain very confident about our ability to deliver attractive long-term growth in sales and earnings.”

Chairman, Amgen Inc Q2 FY2023 Earnings Call · August 3, 2023